Skip to content

King & Wood Mallesons Pulse

  • Topics
    • All Topics
    • Carbon markets
    • Competition & consumer
    • Consumer protection
    • ESG
    • Future energy
    • Hydrogen
    • Inhouse Counsel
    • International Arbitration
    • Intellectual Property
    • Technology
  • Jurisdictions
    • Australia
    • China
    • Hong Kong
    • Singapore
    • Global
  • Specialty Blogs
    • In Competition
    • International Arbitration
    • IP Whiteboard
  • Authors

King & Wood Mallesons Pulse

  • Topics
    • All Topics
    • Carbon markets
    • Competition & consumer
    • Consumer protection
    • ESG
    • Future energy
    • Hydrogen
    • Inhouse Counsel
    • International Arbitration
    • Intellectual Property
    • Technology
  • Jurisdictions
    • Australia
    • China
    • Hong Kong
    • Singapore
    • Global
  • Specialty Blogs
    • In Competition
    • International Arbitration
    • IP Whiteboard
  • Authors

claims

Sampling in Large Construction Cases: the Perfect Marriage of Law and Statistics

Sampling in Large Construction Cases: the Perfect Marriage of Law and Statistics

27 January 2022
By Christopher Seaman
In this post, we summarise we discuss the relevant legal principles around sampling in preparing evidence and provide some pointers on how this can be used in preparing claims for arbitration and litigation. 
Read on
Australian company ordered to pay $10 million for unacceptable advertising claims: TGA uses its power to penalise inappropriate online advertisement and sale of therapeutic goods

Australian company ordered to pay $10 million for unacceptable advertising claims: TGA uses its power to penalise inappropriate online advertisement and sale of therapeutic goods

2 August 2019
By Veg Tran
Read on
It’s only natural: TGA guidelines on ‘natural’ claims in therapeutic goods advertising

It’s only natural: TGA guidelines on ‘natural’ claims in therapeutic goods advertising

13 June 2019
By Tim Craven
The TGA has published guidance on use of the term ‘natural’ and related claims when advertising therapeutic goods to the public.
Read on

Speciality Blogs

  • In Competition
  • International Arbitration
  • IP Whiteboard

More From In Competition

  • In Competition

Trending Topics

  • Dispute resolution & litigation
  • Hong Kong
  • Litigation
  • Technology
View All Topics

Most Viewed

Bilateral relations for Australia & China enter a new chapter

Read More

ASIC flexes muscles in scam and phishing takedowns

Read More
King & Wood Mallesons
©2025 King & Wood Mallesons

Follow Us

  • LinkedIn
  • Facebook
  • Twitter
Subscribe to KWM Pulse
Terms of use & legal notices | Privacy statement
©2025 King & Wood Mallesons